Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
This guide shows how indices are grouped by country and region, enabling easier cross-market comparisons and analysis.
28,656 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
As the fed's preferred inflation metric climbs above 4%, investors face questions about rate paths and portfolio reso...
Nio stunned investors with its first quarterly net profit, driving a sharp rally on a market day shaped by mixed indi...
Artificial intelligence stocks grabbed huge investor attention, but even the most sought-after names can swing sharpl...
Two blue chips face opposite paths as rates stay high and consumer patterns shift. McDonald’s shows earnings growth w...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
The retirement safety net could face headwinds as projected funding gaps loom. This guide explains what could happen,...
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
A fast-growing tech name in the AI space has dazzled investors, but a recent funding move underscored a crucial risk....
A top dividend-focused ETF is delivering gains, but I refuse to stop buying. Here’s how the approach stays discipline...
Geopolitical headlines push crypto traders toward nonstop venues. This piece explains why hyperliquid's token rises w...
When a company’s CEO purchases thousands of shares, investors sit up and take notice. This article breaks down Brady ...